Elizabeth R. Plimack, MD, MS, of Fox Chase Cancer Center in Philadelphia, chaired a session on bladder cancer at the 2017 Genitourinary Cancers Symposium, held February 16–18, 2017, in Orlando, Florida. The session focused on optimizing outcomes in muscle-invasive bladder cancer, and a presentation on genomic markers of response to neoadjuvant chemotherapy.  She discusses the highlights in a video at cancernetwork.com.